Literature DB >> 21962974

Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.

Ronnie Dhaher1, Jamie E Toalston, Sheketha R Hauser, Richard L Bell, David L McKinzie, William J McBride, Zachary A Rodd.   

Abstract

Research indicates opioid antagonists can reduce alcohol drinking in rodents. However, tests examining the effects of opioid antagonists on ethanol seeking and relapse behavior have been limited. The present study examined the effects of two opioid antagonists on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats. Adult P rats were self-trained in two-lever operant chambers to self-administer 15% (vol/vol) ethanol on a fixed-ratio 5 (FR5) versus water on a FR1 concurrent schedule of reinforcement in daily 1-h sessions. After 10 weeks, rats underwent extinction training, followed by 2 weeks in their home cages. Rats were then returned to the operant chambers without ethanol or water to measure responses on the ethanol and water levers for four sessions. After a subsequent 2 weeks in the home cage, without access to ethanol, rats were returned to the operant chambers with ethanol and water available. Effects of antagonists on maintenance responding were tested after several weeks of daily 1-h sessions. Naltrexone (NAL; 1-10mg/kg, subcutaneously [s.c.]; n=8/dose), LY255582 (LY; 0.03-1mg/kg, s.c.; n=8/dose), or vehicle were injected 30min before the first session (in the absence of ethanol), following 2 weeks in their home cages, and for four consecutive sessions of ethanol self-administration under maintenance and relapse conditions. Both NAL and LY reduced responses on the ethanol lever without any fluids present, and ethanol self-administration under relapse and on-going drinking conditions, with LY being more potent than NAL. Both NAL and LY were less effective in reducing responding in the absence of ethanol than in reducing ethanol self-administration. Overall, the results indicate that the opioid system is involved in mediating ethanol seeking, and ethanol self-administration under relapse and on-going alcohol drinking, but that different neurocircuits may underlie these behaviors. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21962974      PMCID: PMC4581853          DOI: 10.1016/j.alcohol.2011.08.011

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  70 in total

1.  Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: I. Periadolescent exposure.

Authors:  Zachary A Rodd-Henricks; Richard L Bell; Kelly A Kuc; James M Murphy; William J McBride; Lawrence Lumeng; Ting-Kai Li
Journal:  Alcohol Clin Exp Res       Date:  2002-11       Impact factor: 3.455

Review 2.  The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Authors:  Helen M Pettinati; Charles P O'Brien; Amanda R Rabinowitz; Shoshana P Wortman; David W Oslin; Kyle M Kampman; Charles A Dackis
Journal:  J Clin Psychopharmacol       Date:  2006-12       Impact factor: 3.153

3.  Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.

Authors:  Tobie Escher; Guy Mittleman
Journal:  Addict Biol       Date:  2006-03       Impact factor: 4.280

4.  Development of an alcohol-deprivation effect in rats.

Authors:  J D Sinclair; R J Senter
Journal:  Q J Stud Alcohol       Date:  1968-12

Review 5.  The opioidergic-alcohol link : implications for treatment.

Authors:  Vania Modesto-Lowe; Eleanor M Fritz
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.

Authors:  David A White; M Lisa Hwang; Stephen G Holtzman
Journal:  Pharmacol Biochem Behav       Date:  2005-07       Impact factor: 3.533

7.  Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone.

Authors:  Roberto Ciccocioppo; Daniel Lin; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Psychopharmacology (Berl)       Date:  2003-03-27       Impact factor: 4.530

8.  Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.

Authors:  Roberto Ciccocioppo; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2002-09       Impact factor: 7.853

9.  Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression.

Authors:  Peter W Marinelli; Douglas Funk; Walter Juzytsch; Zhaoxia Li; A D Lê
Journal:  Eur J Neurosci       Date:  2007-11       Impact factor: 3.386

10.  Memantine enhances the inhibitory effects of naltrexone on ethanol consumption.

Authors:  Alexander Kuzmin; Tove Stenback; Sture Liljequist
Journal:  Eur J Pharmacol       Date:  2008-02-14       Impact factor: 4.432

View more
  12 in total

1.  Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse.

Authors:  A D Lê; Douglas Funk; Steven Lo; Kathleen Coen
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

Review 2.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

Review 3.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 4.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

5.  Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats.

Authors:  Robert A Waeiss; Christopher P Knight; Sheketha R Hauser; Lauren A Pratt; William J McBride; Zachary A Rodd
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

6.  Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J mice.

Authors:  Arthur Tomie; Idu Azogu; Lei Yu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-13       Impact factor: 5.067

Review 7.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

8.  Naltrexone alters alcohol self-administration behaviors and hypothalamic-pituitary-adrenal axis activity in a sex-dependent manner in rats.

Authors:  Steven J Nieto; Cana B Quave; Therese A Kosten
Journal:  Pharmacol Biochem Behav       Date:  2018-02-24       Impact factor: 3.533

9.  Sex Differences in Motivation to Self-Administer Alcohol After 2 Weeks of Abstinence in Young-Adult Heavy Drinkers.

Authors:  Martin Henry Plawecki; Kurt White; Ann E K Kosobud; Nicholas Grahame; Ulrich S Zimmermann; David Crabb; Sean O'Connor
Journal:  Alcohol Clin Exp Res       Date:  2018-08-29       Impact factor: 3.455

10.  An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI.

Authors:  Sarah E Maggio; Meredith A Saunders; Kimberly Nixon; Mark A Prendergast; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Richard L Bell; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2018-10-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.